Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CNR2 Antikörper (3rd Intracellular Loop)

Der Kaninchen Polyklonal anti-CNR2 Antikörper (ABIN7043025) detektiert spezifisch CNR2 in WB und IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Ratte.
Produktnummer ABIN7043025
854,77 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für CNR2 Antikörper (3rd Intracellular Loop) (ABIN7043025)

Target

Alle CNR2 Antikörper anzeigen
CNR2 (Cannabinoid Receptor 2 (CNR2))

Reaktivität

  • 67
  • 28
  • 24
  • 2
  • 1
  • 1
Ratte

Wirt

  • 67
  • 5
  • 1
Kaninchen

Klonalität

  • 68
  • 5
Polyklonal

Konjugat

  • 38
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CNR2 Antikörper ist unkonjugiert

Applikation

  • 57
  • 32
  • 30
  • 24
  • 13
  • 13
  • 10
  • 9
  • 6
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Bindungsspezifität

    • 16
    • 12
    • 10
    • 8
    • 7
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    3rd Intracellular Loop, AA 228-242

    Verwendungszweck

    A Rabbit Polyclonal Antibody to Cannabinoid Receptor 2

    Kreuzreaktivität

    Maus, Ratte

    Homologie

    Mouse - identical Human - 14 out of 15 amino acid residues identical

    Produktmerkmale

    Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) is directed against an intracellular epitope of the rat CB2 receptor. Anti-Cannabinoid Receptor 2 Antibody (ABIN7043025, ABIN7044157 and ABIN7044158) can be used in western blot and immunohistochemistry applications, and recognizes CB2 in rat samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    (C)DRQVPGIARMRLDVR, corresponding to amino acid residues 228-242 of rat CB2 receptor

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200

    FC: The optimal concentration should be determined by the user

    ICC: The optimal concentration should be determined by the user

    IHC: 1:100-1:400

    IP: The optimal concentration should be determined by the user

    Kommentare

    Cited Application: IHC

    Negative Control: (ABIN7235032)

    Blocking Peptide: (ABIN7235032)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Konzentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    CNR2 (Cannabinoid Receptor 2 (CNR2))

    Andere Bezeichnung

    CNR2

    Hintergrund

    Synonyms: CB2, CNR2

    Description: Cannabinoids have been used as pain relievers in Eastern medicine for many years.1 To date, two specific cannabinoid receptors have been identified: cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2).2 The cannabinoid receptors can be distinguished by their amino acid sequence, signaling mechanisms and tissue distribution.2 Both receptors belong to the G-protein coupled receptor superfamily and are coupled to Gi/0 G protein.2,3The CB2 receptor is highly expressed in cells of the immune system such as macrophages, lymphocytes natural killer cells and mast cells but has also been shown to be expressed, by both, in situ-hybridization and in immunohistochemistry, in spleen, thymus, and pancreas.1,2,4 CB2 expression in the brain is still much less characterized than that of CB1. Recently, it was demonstrated that CB2 is expressed in the brain and might have a role in controlling fundamental processes such as proliferation and survival of neural cells.5,6Overexpression of CB2 was reported in several cancers such as prostate, glioma and acute myeloid leukemias.6 In human astrocytoma a direct relationship between CB2 expression and tumor malignancy was demonstrated. Activation of CB2 in vivo by its agonist JWH-133, completely blocked cell growth. In C6 glioma, it was shown that activation of the CB2 by JWH-133 resulted in the internalization of only the CB2 and not CB1 leading to apoptosis of the cells. This may well be a new approach for the treatment of glioma.7

    Gen-ID

    57302

    NCBI Accession

    NM_001841

    UniProt

    Q9QZN9
Sie sind hier:
Chat with us!